Xiaolong Fu

2.7k total citations · 1 hit paper
83 papers, 1.9k citations indexed

About

Xiaolong Fu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Xiaolong Fu has authored 83 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 20 papers in Oncology. Recurrent topics in Xiaolong Fu's work include Lung Cancer Diagnosis and Treatment (24 papers), Lung Cancer Treatments and Mutations (16 papers) and Esophageal Cancer Research and Treatment (14 papers). Xiaolong Fu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (24 papers), Lung Cancer Treatments and Mutations (16 papers) and Esophageal Cancer Research and Treatment (14 papers). Xiaolong Fu collaborates with scholars based in China, United States and Australia. Xiaolong Fu's co-authors include Yongliang Zhao, Pei-wu Yu, Fangyuan Mao, Guoliang Jiang, Yong‐sheng Teng, Yuan Zhuang, Quanming Zou, Liu‐sheng Peng, Wei Duan and Ping Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Xiaolong Fu

76 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway

2017 384 citations Tingting Wang, Yongliang Zhao et al. Gut profile →

Peers

Xiaolong Fu

PRM

ONCOL

IMMUN

SURGE

Kozo Morita Japan

John Holland United States

Weihu Wang China

Marc Bischof Germany

Ming‐Yuan Chen China

Shigeru Yamada Japan

Kenneth R. Olivier United States

Claudia G. Berman United States

Frank Berger Germany

Jinhua Huang China

Kozo Morita Japan

Xiaolong Fu

375 ×0.6

PRM

629 ×1.1

ONCOL

179 ×0.4

IMMUN

828 ×2.5

476 ×1.5

SURGE

Citations per year, relative to Xiaolong Fu Xiaolong Fu (= 1×) peers Kozo Morita

Countries citing papers authored by Xiaolong Fu

Since Specialization

Citations

This map shows the geographic impact of Xiaolong Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Fu more than expected).

Fields of papers citing papers by Xiaolong Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Fu. The network helps show where Xiaolong Fu may publish in the future.

Co-authorship network of co-authors of Xiaolong Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Fu. A scholar is included among the top collaborators of Xiaolong Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Fu. Xiaolong Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yuling, Shuai Zhang, Xiaolong Fu, et al.. (2025). Ag NPs-doped Cu3(HHTP)2 MOF-based electrochemiluminescence immunoassay for prostate-specific antigen via glucose oxidase mediated etching strategy. Electrochimica Acta. 548. 147924–147924.

Kou, Yong, Hongyu Yang, Tong Xi, et al.. (2025). Cu-induced thermal oxidation pathway of Al powders: Enhancing the energy release efficiency of Al-based composite energetic microunits. Combustion and Flame. 282. 114517–114517.

Kou, Yong, Hongchao Ji, Xiaolong Fu, et al.. (2025). Autonomous thermite-recycled cobalt nanoreactors on aluminum: Synergistic interfacial redox loops for ultrafast thermal decomposition and combustion of various energetic materials. Defence Technology.

Kou, Yong, Hongyu Yang, Jiahao Yu, et al.. (2025). In Situ Generation of Ni Nanoparticles on Al Powder Surface via F‐Ion‐Mediated Oxide Layer Disruption: Enhanced the Energy Release of Oxidizer/Al Composite Energetic Microunits. Small. 21(32). e2504218–e2504218. 1 indexed citations

Zhao, Lu, et al.. (2023). CoADS: Cross attention based dual-space graph network for survival prediction of lung cancer using whole slide images. Computer Methods and Programs in Biomedicine. 236. 107559–107559. 8 indexed citations

Fu, Xiaolong, et al.. (2023). The effect of perceived stress for work engagement in volunteers during the COVID-19 pandemic: the mediating role of psychological resilience and age differences. PeerJ. 11. e15704–e15704. 1 indexed citations

Duan, Yanhua, Jiyong Wang, Yan Shao, et al.. (2023). AS-NeSt: A Novel 3D Deep Learning Model for Radiation Therapy Dose Distribution Prediction in Esophageal Cancer Treatment With Multiple Prescriptions. International Journal of Radiation Oncology*Biology*Physics. 119(3). 978–989. 7 indexed citations

Mao, Xiaowei, Jiabing Liu, Fang Hu, et al.. (2022). Serum NSE is Early Marker of Transformed Neuroendocrine Tumor After EGFR-TKI Treatment of Lung Adenocarcinoma. SHILAP Revista de lepidopterología. 3 indexed citations

Yu, Wen, et al.. (2022). A decision support framework for postoperative radiotherapy in patients with pathological N2 non-small cell lung cancer. Radiotherapy and Oncology. 173. 313–318. 4 indexed citations

10.

Qian, Liqiang, Yinjie Zhou, Xiaoke Chen, et al.. (2022). A random forest algorithm predicting model combining intraoperative frozen section analysis and clinical features guides surgical strategy for peripheral solitary pulmonary nodules. Translational Lung Cancer Research. 11(6). 1132–1144. 6 indexed citations

11.

Yu, Weiwei, Xiaolong Fu, Xu‐Wei Cai, Menghong Sun, & Yan‐Mei Guo. (2021). Identification of differentially expressed proteins in the locoregional recurrent esophageal squamous cell carcinoma by quantitative proteomics. Journal of Gastrointestinal Oncology. 12(3). 991–1006. 1 indexed citations

12.

Zhao, Yongliang, Xiaosong Wang, Wei Duan, et al.. (2018). Short-term clinical efficacies of Da Vinci robotic surgical system-assisted and laparoscopy-assisted radical gastrectomy for locally advanced gastric cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 17(6). 581–587. 1 indexed citations

13.

Li, Xiaoyang, et al.. (2018). Detection of epithelial growth factor receptor (EGFR) mutations on CT images of patients with lung adenocarcinoma using radiomics and/or multi-level residual convolutionary neural networks. Journal of Thoracic Disease. 10(12). 6624–6635. 33 indexed citations

14.

Wang, Tingting, Yongliang Zhao, Liu‐sheng Peng, et al.. (2017). Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut. 66(11). 1900–1911. 384 indexed citations breakdown →

15.

Yu, Weiwei, Li Chu, Kuaile Zhao, et al.. (2017). A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinoma. Journal of Cancer. 8(18). 3755–3763. 3 indexed citations

16.

Kong, Feng‐Ming, Lujun Zhao, Lühua Wang, et al.. (2017). Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation. Translational Lung Cancer Research. 6(6). 625–634. 20 indexed citations

17.

Zhao, Kuaile, Xichun Hu, Xianghua Wu, et al.. (2011). A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus. Investigational New Drugs. 30(4). 1585–1590. 26 indexed citations

18.

Jiang, Guoliang, Lijuan Wang, Qian Hao, et al.. (2004). Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: A clinical Phase II trial. International Journal of Radiation Oncology*Biology*Physics. 61(1). 70–75. 14 indexed citations

19.

Zhu, Guopei, Shaoqin He, Xiaolong Fu, Guoliang Jiang, & Taifu Liu. (2004). Radiotherapy and prognostic factors for thymoma: A retrospective study of 175 patients. International Journal of Radiation Oncology*Biology*Physics. 60(4). 1113–1119. 54 indexed citations

20.

Fu, Xiaolong, et al.. (1997). Hyperfractionated accelerated radiation therapy for nonsmall cell lung cancer: Clinical phase trial. International Journal of Radiation Oncology*Biology*Physics. 39(3). 545–552. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact